Library

Pharmacology and biochemistry

Mexidol: modern aspects of pharmacokinetics and pharmacodynamics

Authors:
A.V. Schulkin

FSBEN in the Ryazan State Medical University of the Russian Federation, Ryazan

Place of publication: Farmatek magazine Special Psychiatry / Neurology / 2016

Mexidol is an original domestic drug. The article describes the history of the creation of the drug, outlines modern ideas about its pharmacokinetics (including data on the penetration of Mexidol into mitochondria, as well as its effect on the activity of cytochroma-R450 isform 3A4 and protein-conveyor glycoprotein-r) and pharmacodynamics. From a biochemical point of view, the appropriateness of the use of Mexidol with hypoxia of the brain, the development of oxidative stress, with glutamate exaytotoxicity is substantiated. The comparison of Mexidol and its generics, as well as studies proving the safety of this drug, are presented.

Keywords: Mexidol, ethylmethylhydroxypirinate, pharmacokinetics, pharmacodynamics, safety

Mexidol: a spectrum of pharmacological effects

Author:
T.A. Voronin

Nii pharmacology named after V.V. Zakusov RAMS, Moscow

Place of publication:
a journal of neurology and psychiatry, No. 12, 2012

Summary:
Mexidol (2-El-methyl-3-gydro Xipina Ridina Succinate)-a domestic original antioxidant and anti-hyphyxant, created at the Research Institute of Pharmacology of the RAMS in the mid-80s. Mexol consists of two related and functionally significant compounds: 2-ethyl-6-methyl-3-hydroxypyridine and amber acid. The presence of 3-hydroxypyridine in the structure of Mexidol provides a complex of its antioxidant and membranotropic effects, the ability to reduce glutamate excanitotoxicity, modulate the functioning of receptors, which fundamentally distinguishes Mexol from other preparations containing amber acid. The presence of succinate in the structure of Mexidol distinguishes it from Emoxypin and other 3-oxypyridine derivatives, since the succinate is functionally significant for many processes occurring in the body and, in particular, is a substrate for increasing energy metabolism in the cell.

Mexidol: the main neuropsychotropic effects and the mechanism of action

Author:
T.A. Voronin

GU "Nii Pharmacology named after V.V. Zakusov "RAMS, Moscow

Place of publication:
Pharmacate, No. 6, 2009

Summary:
The article presents viewing data on pharmacological effects and pharmacokinetics of Mexidol. Neuroprotective, anti -hypic, anti -ischemic, nootropic, anti -stress, anxiolytic, anticonvulusal, anti -alcohol, anti -anatherogenic, heroesidal action of Mexidol is considered. Particular attention is paid to the effects of Mexidol in the treatment of diseases occurring with neurodegeneration, primarily acute and chronic disorders of cerebral circulation. Information is presented about the polycomponent mechanism of action of Mexidol, the important links of which are its antioxidant, membrane effects, the ability to modulate the functioning of receptors and membrane -raised enzymes, as well as restore the neurotransmitted balance.

Pharmacology of antioxidants based on 3-oxypyridine

Authors:
V.E. Novikov, L.A. Kovaleva, S.O. Losenkova, E.I. Klimkina

Smolensk State Medical Academy

Year of publication: 2004

Summary:
in recent years, close attention of pharmacologists and clinicians as promising drugs that effectively regulate oxidation and peroxidation processes attracted compounds of heteroamatic phenols, in particular, 3-oxypyrin derivatives. 3-oxypyridine derivatives (3-OP) belong to the simplest heterocyclic analogues of aromatic phenols and in this regard show antioxidant and anti-radical properties. They are structural analogues of the compounds of the Vitamin B6 group (pyridoxol, pyridoxal and pyridoxamine), playing an important role in the life of the body. The synthesis and analysis of the physicochemical properties of a number of original derivatives of 3-Op was carried out by L.D. Smirnov, K.M. Dyumaev, V.I. Kuzmin, and their pharmacological study was carried out in the laboratory of psychopharmacology of the Research Institute of Pharmacology of the Russian Academy of Sciences under the guidance of a honored science figure of Professor T.A. Voronina.

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com